structural insight type-ii mitochondrial nadh dehydrogenases 
single-component type-ii nadh dehydrogenases ndh-2s serve alternatives multisubunit respiratory complex type-i nadh dehydrogenase ndh- also called nadh: ubiquinone oxidoreductase ec catalysing electron transfer nadh ubiquinone mitochondrial respiratory chain yeast ndh ndi1 oxidizes nadh matrix side reduces ubiquinone maintain mitochondrial nadh/nad+ homeostasis ndi1 potential therapeutic agent human diseases caused complex defects- particularly parkinsons disease expression restores mitochondrial activity animals complex deficiency ndh-2s pathogenic microorganisms viable targets new antibiotics solve crystal structures ndi1 substrate-free nadh- ubiquinone-and nadh-ubiquinone-bound states help understand catalytic mechanism ndh-2s find ndi1 homodimerization carboxy-terminal domain critical catalytic activity membrane targeting structures reveal two ubiquinone-binding sites uqi uqii ndi1 nadh uqi can bind ndi1 simultaneously form substrate-protein complex propose uqi interacts fad act intermediate electron transfer nadh transfers electrons fad-uqi complex uqii together data reveal regulatory catalytic mechanisms ndi1 may facilitate development targeting ndh-2s potential therapeutic applications 
